ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

CD47 Innate Immune Checkpoint Enhances Islet Engraftment Following Intraportal Transplantation by Mitigating Instant Blood Mediated Inflammatory Reaction

P. Shrestha, L. Batra, M. T. Malik, M. Tan, E. S. Yolcu, H. Shirwan

Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY

Meeting: 2020 American Transplant Congress

Abstract number: B-357

Keywords: Engraftment, Graft failure, Inflammation, Islets

Session Information

Session Name: Poster Session B: Islet cell and cell Transplantation

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Transplantation of islets into hepatic portal vein is associated with significant islet mass loss immediate post-transplantation. Instant blood mediated inflammatory reaction (IBMIR), characterized by non-specific thrombotic and inflammatory reactions orchestrated by innate immune cells, is the main culprit of islet graft loss. CD47/SIRPα axis has been shown to play an important role in downregulating innate immune responses, including activation of neutrophils, platelets, macrophages, and dendritic cells. Thus, we assessed the efficacy of CD47/SIRPα innate immune checkpoint in enhancing islet graft engraftment by mitigating IBMIR.

*Methods: A synthetic gene encoding the extracellular domain of CD47 C-terminus to a modified form of streptavidin, (SA)-CD47, was generated and expressed in insect cells. SA-CD47 protein was purified and effectively displayed on the surface of biotinylated cells and islets by taking the advantage of high interaction between biotin and SA. The efficacy of SA-CD47 in enhancing engraftment and mitigating IBMIR was assessed in an in vitro loop assay as well as in vivo in an intraportal transplantation model.

*Results: Rat splenocytes engineered with SA-CD47 protein were refractory to phagocytosis by mouse macrophages. Biotinylation of islets followed by engineering with SA-CD47 protein did not impair islet viability and insulin secretion function. Importantly, SA-CD47-engineered islets showed significantly enhanced engraftment and survival as compared with SA-engineered controls in a minimal mass syngeneic intraportal transplantation model. SA-CD47-engineered islet recipients had significantly less intrahepatic infiltration of inflammatory cells and reduced levels of inflammatory mediators, including high-mobility group box-1, tissue factor, and IL-1β. Additionally, SA-CD47 protected islet morphology and blocked intra-islet infiltration of CD11b+ granulocytes.

*Conclusions: CD47 serves an effective innate immune checkpoint that mitigates IBMIR, leading to improved islet engraftment and survival with important clinical implication for auto and allogeneic islet transplantation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Shrestha P, Batra L, Malik MT, Tan M, Yolcu ES, Shirwan H. CD47 Innate Immune Checkpoint Enhances Islet Engraftment Following Intraportal Transplantation by Mitigating Instant Blood Mediated Inflammatory Reaction [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/cd47-innate-immune-checkpoint-enhances-islet-engraftment-following-intraportal-transplantation-by-mitigating-instant-blood-mediated-inflammatory-reaction/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences